Trial Search

Current Search Criteria:

Intervention: fluorodeoxyglucose F 18

Found 597 matching trials

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

PHASE2

RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...

Status

Terminated

Location

Stanford Cancer Center

Start Date

2013-05-24

Trial ID

NCT01390584

Treatments Being Tested

Doxorubicin Bleomycin Vinblastine PET INRT Dacarbazine Etoposide Cyclophosphamide Vincristine Procarbazine Prednisone

Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection?

The purpose of this study is to identify association between cerebrospinal ...

Status

Unknown

Location

University Hospital, Tours

Start Date

2015-07

Trial ID

NCT02843906

Treatments Being Tested

Lombar Punction Magnetic Resonance Imaging (MRI)Positron-Emission Tomography (TEP) /(FDG)Psychiatric tests Neuropsychological Tests Apolipoprotein (ApoE) detection

A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques

PHASE1

This is an adaptive Positron Emission Tomography/ Computed Tomography (PET/...

Status

Terminated

Location

GSK Investigational Site

Start Date

2015-08-12

Trial ID

NCT02350426

Treatments Being Tested

Gadobutrol 18F-FDG 18F-GE-180

Para-Aortic Lymph Nodal Staging & Evaluation of Treatment Outcome by 18F FDG-PET in Advanced Cancer Cervix

N/A

18F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Imaging has b...

Status

Completed

Location

Tata Memorial Hospital

Start Date

2005-09

Trial ID

NCT00193752

Treatments Being Tested

PET IMAGING

FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy

RATIONALE: Diagnostic procedures, such as fludeoxyglucose F 18 (\^18FDG) po...

Status

Terminated

Location

Jonsson Comprehensive Cancer Center at UCLA

Start Date

2007-03-30

Trial ID

NCT00424138

Treatments Being Tested

FDG

Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy

EARLY_PHASE1

This is a single arm study to determining the value of apoptotic molecular ...

Status

Unknown

Location

Affiliated Hospital of Jiangnan University

Start Date

2023-01

Trial ID

NCT05828238

Treatments Being Tested

[18F]SF-DEVD-2 [18F]-FDG

Molecular Imaging to Capture Disease Heterogeneity in Acute Myeloid Leukemia

The current understanding of acute myeloid leukemia (AML) is that one site ...

Status

Unknown

Location

Juravinski Hospital and Cancer Center

Start Date

2016-04

Trial ID

NCT02682732

Treatments Being Tested

FDG-PET/CT guided bone marrow sampling

Illiteracy and Vulnerability to Alzheimer's Disease: Evaluation of Amyloid Pathology by PET Imaging

The goal of this study is to improve the diagnosis of Alzheimer's disease (...

Status

Completed

Location

Hospital Avicenne-Neurology

Start Date

2015-12-12

Trial ID

NCT02494531

Treatments Being Tested

Fluorodeoxyglucose-PET florbetapir F 18-PET

BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS

N/A

The advent of immunotherapy (immune checkpoint inhibitors \[ICI\]) has been...

Status

Active Not Recruiting

Location

Beatson West of Scotland Cancer Centre

Start Date

2022-08-30

Trial ID

NCT06597045

Treatments Being Tested

PET/CT with 18-FDG

WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC

Response evaluation with FDG-PET and free circulating DNA in patients with ...

Status

Unknown

Location

University Copenhagen

Start Date

2018-02-28

Trial ID

NCT03481101

Treatments Being Tested

PET/CT

Previous Next